This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
ChinaBio Partnering Forum 2020

REPORT: State of China Life Science - 2020 H1

Posted by on 05 August 2020
Share this article

Download this new exclusive ChinaBio® report with in-depth analysis of investment and partnering activity in China for 2020 H1 to discover the factors driving China life science investment. Learn how VC, IPO, and Partnering have rebounded despite COVID-19, but how M&A continues to slump. Read the latest analysis of life science investment activity to get ahead for ChinaBio® Partnering Forum Digital, August 25-27!

Download Now -  SPECIAL REPORT: 2019 Biopharma Outlook Facing an Uncertain Future

Report Details:

• New VC/PE funds rebound to 2018 levels

• Drug company investments back on top

• M&A deal values set to plummet 60%

• IPO funds raised could set another record at $11B

• New record for partnering on the way to $29B, up 65%

Share this article

Sign up for Partnering, Business Development & Licensing email updates